Medi-Green is a wholly-owned subsidiary of Beleave Inc. and was acquired by the company earlier this year. The two stores mark the first new locations since the acquisition.
“First, we’re thrilled to be opening our new location in Montreal, which will be our first store in Quebec, as we feel there is tremendous opportunity in that market,” said Beleave CEO, Andrew Wnek. “Also, with the addition of our new Londonlocation, we’re coming through on our commitment to provide the residents of Ontario with quality and accessible medicinal cannabis in a safe and trusted environment. We have aggressive plans for expanding the Medi-Green brand and these two new stores are just the beginning.”
The Montreal location will be the first to open in mid-September. At 1530 sq. ft. it will be located at 4123 St. Denis street in the heart of the popular Plateau Mont-Royal district. Long-recognized as a hub for art, food, and culture, the shops on St. Denis are an integral part of the community, close to the subway, and are a destination for tourists and locals alike. Employee training and onboarding for that location is already underway.
In late-September, Medi-Green will be opening the London store. With approximately 1500 sq. ft. of space, it will be located at 211 Dundas Street. Employee training and onboarding will begin on September 3rd.
“With the new stores, Medi-Green’s superior customer service and respected expertise will be available to even more Canadians,” said Beleave CFO, Bojan Krasic. “As the distribution and point of sale landscape evolves, we will continue to invest in additional locations, employee training, and community outreach to be advantageously positioned for new opportunities as they arise.”
ABOUT BELEAVE INC.
Beleave is a biotech company who’s wholly-owned subsidiary Beleave Kannabis Corp. is licensed to cultivate and sell medical cannabis and produce cannabis oils and extracts pursuant to Health Canada’s Access to Cannabis for Medical Purpose Relations. Beleave has developed a network of medical cannabis clinics under the Medi-Green banner and has applied for various patents to broaden its strong research focused foundation.
This news release contains “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). The use of any of the words “plan”, “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and other similar words, or statements that certain events or conditions “may” or “will” occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.